NESN:SIXNestle S.A. Analysis
Data as of 2026-06-14 - not real-time
CHF 79.81
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
Nestlé’s share price is trading just above its short‑term moving averages, with the 20‑day SMA nudging higher than the 50‑day SMA and both comfortably above the 200‑day SMA, reinforcing a modest bullish bias. The MACD histogram is positive and the signal line has turned bullish, while the RSI sits in a neutral‑to‑slightly‑positive zone, suggesting momentum is intact without signs of overextension. Support remains solid near the recent low, and the price is comfortably below the next resistance level, giving the stock room to move higher. Volatility over the past month is moderate, yet the computed beta is exceptionally low, indicating that the stock’s price movements are largely insulated from broader market swings, a typical trait for a consumer‑defensive staple.
Fundamentally, Nestlé delivers strong profitability margins and a robust return on equity, supported by healthy operating and free cash flow generation. Although revenue growth has been flat to slightly negative, the company’s diversified product portfolio and global footprint cushion earnings. The dividend yield is attractive and the payout ratio, while high, is underpinned by solid cash generation, making the dividend sustainable. Valuation metrics point to roughly a ten‑percent upside versus the current price, and analyst consensus remains a “buy” with target prices well above today’s level, underscoring the stock’s appeal for both income and modest capital appreciation.
Fundamentally, Nestlé delivers strong profitability margins and a robust return on equity, supported by healthy operating and free cash flow generation. Although revenue growth has been flat to slightly negative, the company’s diversified product portfolio and global footprint cushion earnings. The dividend yield is attractive and the payout ratio, while high, is underpinned by solid cash generation, making the dividend sustainable. Valuation metrics point to roughly a ten‑percent upside versus the current price, and analyst consensus remains a “buy” with target prices well above today’s level, underscoring the stock’s appeal for both income and modest capital appreciation.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Bullish MACD crossover confirming upward momentum
- Price positioned above key short‑term moving averages
- Support level holding firmly with stable volume
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Undervalued relative to analyst target median
- Attractive dividend yield with sustainable payout
- Strong cash flow and high return on equity
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Defensive consumer‑staples positioning provides resilience
- Globally diversified brand portfolio reduces geographic concentration
- Low beta and stable earnings support a long‑term hold
Key Metrics & Analysis
Financial Health
Revenue Growth-2.20%
Profit Margin10.05%
P/E Ratio22.7
ROE26.53%
ROA6.53%
Debt/Equity175.00
P/B Ratio6.3
Op. Cash FlowCHF15.9B
Free Cash FlowCHF6.2B
Technical Analysis
TrendBullish
RSI56.7
SupportCHF 76.18
ResistanceCHF 81.07
MA 20CHF 78.60
MA 50CHF 78.44
MA 200CHF 77.60
MACDBullish
VolumeStable
Fear & Greed Index89.86
Valuation
Fair ValueCHF 12.03
Target PriceCHF 87.87
Upside/Downside10.10%
GradeUndervalued
TypeValue
Dividend Yield3.88%
Risk Assessment
Beta0.05
Volatility19.81%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.